ROI Investment Partners
VC Fund
Seoul, South Korea
ROI Investment Partners is a VC fund in Seoul focused on Biotechnology and Manufacturing. Dadam Investment is a venture investment firm that discovers and supports promising small and medium-sized enterprises.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 13%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries ROI Investment Partners invests in
Stages ROI Investment Partners invests in
Countries ROI Investment Partners invests in
Round sizes
Round size
- Series A
- $1.5M–$5.8M
- Series B
- $3.7M–$6.4M
- Venture - Series Unknown
- $5.9M–$14M
Investment Focus
Industry
- Biotechnology 4 (17%)
- Manufacturing 4 (17%)
- Biopharma 3 (13%)
- Pharmaceutical 3 (13%)
- Energy 2 (9%)
Stage
- Series A 7 (30%)
- Venture - Series Unknown 7 (30%)
- Series B 3 (13%)
- Funding Round 2 (9%)
- Seed 1 (4%)
Country
- South Korea 21 (91%)
- United States 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Future Connect
|
Livfarm is an online platform that delivers fresh vegetables and salad samplers. | $5.8M / Series A / Nov 26, 2025 | |
kukka
|
kukka is a provider of flower subscription services. | Series B / Aug 30, 2025 | |
Big Value
|
Big Value is a price analysis for multiplex houses. | $3.7M / Series B / Jun 09, 2025 | |
IBEX Medical System
|
IBEX Medical System designs and develops an automatic control and mirroring system that uses an LCD touch screen interface to provide quick and accurate operational service. The company offers a hyperbaric oxygen chamber that meets the design standards for hyperbaric pressure vessels and international certification standards. In addition tochecking chamber conditions and patient information on mobile devices, medical staff can also check it in real-time on their mobile devices. | $9.7M / Series C / Mar 14, 2025 | |
LISCure Biosciences
|
LISCure Biosciences is a developer of bacteria-mediated immunotherapy designed to treat tumors as well as degenerative neurological, autoimmune and metabolic diseases. The company currently has seven pipelines of medicine and two pipelines of health-functioning food and is considering the introduction of two more pipes. | $13.6M / Venture - Series Unknown / Jan 10, 2025 | |
Dalol
|
Dalol is a bakery that sells snacks, cakes, and rice chips. | $1.5M / Series A / Dec 20, 2023 | |
Oasis Business
|
Oasis Business is an information services company that provides AI solutions to the finance, construction, and distribution industries. | $3.8M / Series A / May 24, 2023 | |
CLIKA
|
CLIKA is a software company that develops optimization tools to streamline the execution of artificial intelligence projects. The company provides an AI compression platform that enables compact, accelerated, and hardware-ready deployment—across cloud, on-prem, and edge environments. | $1M / Pre-Seed / Sep 15, 2022 | |
Dnature Bio Labs
|
Dnature Bio Labs is a biotechnology research and development company that develops biopharmaceuticals for nervous system diseases. | $3M / Series A / Jul 30, 2021 | |
PeopleBio
|
PeopleBio develops diagnosis detection products and specializes in developing diagnostics for protein misfolding diseases. | $33.6M / Post-IPO Equity / Jun 21, 2021 | |
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does ROI Investment Partners invest in?
ROI Investment Partners invests primarily in Biotechnology, Manufacturing and Biopharma startups, most often at Series A and Venture - Series Unknown stage. Most of the 23 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is ROI Investment Partners's check size?
ROI Investment Partners typically joins rounds of $1.5M–$5.8M at Series A, $3.7M–$6.4M at Series B and $5.9M–$14M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds ROI Investment Partners participates in.
When did ROI Investment Partners last invest?
The most recent investment recorded for ROI Investment Partners closed in Nov 2025. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
